We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Dose-finding Study of GSK2248761 in Antiretroviral Therapy-experienced Subjects With NNRTI-resistant HIV Infection (SONNET)

This study has been terminated.
(Study placed on Clinical Hold)
Sponsor:
ClinicalTrials.gov Identifier:
NCT01199731
First Posted: September 13, 2010
Last Update Posted: October 12, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborator:
GlaxoSmithKline
Information provided by (Responsible Party):
ViiV Healthcare
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: July 19, 2011
  Primary Completion Date: July 19, 2011 (Final data collection date for primary outcome measure)
  Certification or Request for Extension to Delay Results Submission: March 29, 2012